Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.62 (
caspase-9
)
7,507
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Huntingtin-interacting protein 1
(
HIP1
) is a cofactor in clathrin-mediated vesicle trafficking. It was first implicated in cancer biology as part of a chromosomal translocation in leukemia. Here we report that
HIP1
is expressed in prostate and colon tumor cells, but not in corresponding benign epithelia. The relationship between
HIP1
expression in primary prostate cancer and clinical outcomes was evaluated with tissue microarrays.
HIP1
expression was significantly associated with prostate cancer progression and metastasis. Conversely, primary prostate cancers lacking
HIP1
expression consistently showed no progression after radical prostatectomy. In addition, the expression of
HIP1
was elevated in prostate tumors from the transgenic mouse model of prostate cancer (TRAMP). At the molecular level, expression of a dominant negative mutant of
HIP1
led to
caspase-9
-dependent apoptosis, suggesting that
HIP1
is a cellular survival factor. Thus,
HIP1
may play a role in tumorigenesis by allowing the survival of precancerous or cancerous cells.
HIP1
might accomplish this via regulation of clathrin-mediated trafficking, a fundamental cellular pathway that has not previously been associated with tumorigenesis.
HIP1
represents a putative prognostic factor for prostate cancer and a potential therapy target in prostate as well as colon cancers.
...
PMID:Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival. 1216 54